Retractable Technologies (RVP)
Makes retractable syringes, safety needles, and blood-collection devices.
Something off on this page? Send us feedback.
Sells retractable syringes, safety needles, and blood-collection devices primarily through distributors, pairing automated in-device needle retraction with other safety products. The single-segment business depends on hospital purchasing channels, regulated manufacturing, Chinese suppliers, and a founder-held patent license.
Designs and sells VanishPoint retractable syringes, EasyPoint retractable needles and blood-collection products, plus IV safety catheters, tube holders, and catheter-hub products. Automated retraction occurs within the injection or collection device, aiming to reduce needlestick exposure and device reuse.
Generates recurring product revenue largely through U.S. general-line and specialty distributors, while serving international distributors and health-care customers directly. Manufacturing combines its Little Elm campus with Chinese contract manufacturers, even as selected production moves domestically in response to tariffs.
Operates as a founder-controlled single segment. Hospital group purchasing organizations and purchasing representatives shape market access; operations remain subject to device regulation, quality requirements, an open EasyPoint recall, government-backed capacity obligations, and founder-held patent licensing.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $39.9M · Total debt $715.9K · Total assets $141.7M · Shareholders' equity $72.9M
- Revenue
- $7.2M
- Operating income
- −$5.1M
- Net income
- $2.8M
No dividends on record.
| Institutions | 8.81% | 2.64M shares | |
|---|---|---|---|
| 33 holders · as of Jun 30, 2026 | |||
| Insiders | 76.61% | 22.94M shares | |
| 4 holders · as of Aug 29, 2025 | |||
| Other | 14.58% | 4.36M shares | |
| remainder | |||
29.94M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Thomas J. ShawInsider | 55.04% | 16.48M | filed Aug 29, 2025 |
Braden M LeonardInsider | 12.48% | 3.74M | filed May 2, 2022 |
Lillian E. SalernoInsider | 5.01% | 1.50M | filed Jan 26, 2021 |
Suzanne M. AugustInsider | 4.08% | 1.22M | filed Jan 19, 2021 |
Vanguard Capital Management LLCInstitution | 1.94% | 581,736 | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- BD
Broad safety syringe, safety needle, and blood-collection leader.
- Cardinal Health
Safety syringe and needle supplier with major U.S. channel reach.
- Embecta
Large insulin-syringe and safety-needle rival in diabetes injection.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Retractable Technologies | $0.6831 | −3.78% | $21.3M | — | — | 0.6 | −31.1% |
| BD | $181.88 | +0.65% | $49.79B | 54.4 | 13.7 | 2.4 | −9.6% |
| Cardinal Health | $226.16 | +0.18% | $52.87B | 31.2 | 18.1 | 0.2 | +5.8% |
| Embecta | $5.47 | +3.21% | $314.4M | 3.6 | 3.4 | 0.3 | −8.1% |
| Median | 31.2 | 13.7 | 0.3 | −8.1% |